Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia

ConclusionConsiderable research has been carried out into the increase in BPD, which has resulted from improvements in neonatal survival. Key areas of research include repeated surfactant administration, using surfactant as a vehicle for budesonide and stem cell therapy.This article is protected by copyright. All rights reserved.

Source: Acta Paediatrica - November 28, 2017 Category: Pediatrics Authors: J M Hasco ët, J C Picaud, I Ligi, T Blanc, P Daoud, V Zupan, F Moreau, I Guilhoto, M Rouabah, C Alexandre, E Saliba, L Storme, J Patkai, M Pomedio, I Hamon Tags: Review Article Source Type: research